Serum levels of oncostatin M (a gp 130 cytokine): an inflammatory biomarker in periodontal disease

References

• Abbas AK, Lichtman AH. (2003). Cellular and Molecular Immunology, 5th edn. Philadelphia: Saunders.
   Google Scholar
• Beck JD, Offenbacher S. (2005). Systemic effects of periodontitis: epidemiology of periodontal disease and cardiovascular disease. J Periodontol 76:2089–100.
   PubMed Web of Science ®Google Scholar
• Brown TJ, Rowe JM, Liu JW, Shoyab M. (1991). Regulation of IL-6 expression by oncostatin M. J Immunol 147:2175–80.
   PubMed Web of Science ®Google Scholar
• Bruce AG, Hoggatt IH, Rose TM. (1992). Oncostatin M is a differentiation factor for myeloid leukemia cells. J Immunol 149:1271–5.
   PubMed Web of Science ®Google Scholar
• Cai J, Gill PS, Masood R, Chandrosoma P, Jung B, Law RE, Radka SF. (1994). Oncostatin-M is an autocrine growth factor in Kaposi’s sarcoma. Am J Pathol 145:74–9.
   PubMed Web of Science ®Google Scholar
• Ebersole JL, Machen RL, Steffen MJ, Willmann DE (1997). Systemic acute-phase reactants, C-reactive protein and haptoglobin, in adult periodontitis. Clin Exp Immunol 107:347–52.
   PubMed Web of Science ®Google Scholar
• Friedewald VE, Kornman KS, Beck JD, Genco R, Goldfine A, Libby P, et al. (2009). The American Journal of Cardiology and Journal of Periodontology Editors’ Consensus: periodontitis and atherosclerotic cardiovascular disease. Am J Cardiol 104:59–68.
   PubMed Web of Science ®Google Scholar
• Gemmell E, Seymour GJ. (2004). Immunoregulatory control of Th1/Th2 cytokine profiles in periodontal disease. Periodontol 2000 35:21–41.
   PubMed Web of Science ®Google Scholar
• Goren I, Kampfer H, Muller E, Schiefelbein D, Pfeilschifter J, Frank S. (2006). Oncostatin M expression is functionally connected to neutrophils in the early inflammatory phase of skin repair: implications for normal and diabetes-impaired wounds. J Invest Dermatol 126:628–37.
   PubMed Web of Science ®Google Scholar
• Halin U-R, Agnieszka W, Henryk S, Tadeusz R. (2000). Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma. Eur Cytokine Netw 11:443–51.
   PubMed Web of Science ®Google Scholar
• Hui W, Bell M, Carroll G. (1997). Detection of oncostatin M in synovial fluid from patients with rheumatoid arthritis. Ann Rheum Dis 56:184–7.
   PubMed Web of Science ®Google Scholar
• Iacopino AM. (2001). Periodontitis and diabetes interrelationships: role of inflammation. Ann Periodontol 6:125–37.
   PubMedGoogle Scholar
• Jeffcott MJ, Haut JC, Guers N et al. (2003). Periodontal disease and preterm birth: result of a pilot intervention study. J Periodontol 74:1214.
   PubMed Web of Science ®Google Scholar
• Katancik JA, Kritchevsky S, Weyant RJ, Corby P, Bretz W, Crapo RO et al. (2005). Periodontitis and airway obstruction. J Periodontol 76:2161–7.
   PubMed Web of Science ®Google Scholar
• Kornman KS, Page RC, Tonetti MS. (1997). The host response to the microbial challenge in periodontitis: assembling the players. Periodontol 2000 14:33–53.
   PubMed Web of Science ®Google Scholar
• Lin S-J, Chen Y-L, Kuo MY-P, Li C-L, Lu H-K. (2005). Measurement of gp130 cytokine oncostatin M and IL-6 in gingival crevicular fluid of patients with chronic periodontitis. Cytokine 30:160–7.
   PubMed Web of Science ®Google Scholar
• Loe H, Silness J. (1963). Perioontal disease in pregnancy. I: Prevalence and severity. Acta Odontol Scand 21:533.
   PubMedGoogle Scholar
• Loe H. (1993). Periodontal diseases: sixth complication of diabetes mellitus. Diabetes Care 16 (Suppl. 1):329.
   PubMed Web of Science ®Google Scholar
• Loos BG, Craandijk J, Hoek FJ, Wertheim-van Dillen PM, van der Velden V. (2000). Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 71:1528–34.
   PubMed Web of Science ®Google Scholar
• Lopez NJ, Smith PC, Gutierrez J. (2002). Periodontal therapy may reduce the risk of preterm low birth in women with periodontal disease: a randomized controlled trial. J Periodontol 73:911–24.
   PubMed Web of Science ®Google Scholar
• Lu H-K, Chen Y-L, Chang H-C, Li C-L, Kuo MY-P. (2006). Identification of the OPG/RANKL system in gingival crevicular fluid and tissue of patients with chronic periodontitis. J Periodont Res 41:354–60.
   PubMed Web of Science ®Google Scholar
• Malthaner SC, Moore S, Mills M et al. (2002). Investigation of the association between angiographically defined coronary artery disease and periodontal disease. J Periodontol 73:1169.
   PubMed Web of Science ®Google Scholar
• Manicourt DH, Poilvache P, Van Egeren A, Devogelaer JP, Lenz ME, Thonar EJ. (2000). Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis. Arthritis Rheum 43:281– 8.
   PubMed Web of Science ®Google Scholar
• Mealey BL. (1999). Influence of periodontal infections on systemic health. Periodontol 2000 21:197
   PubMed Web of Science ®Google Scholar
• Modur V, FeldhausMJ Weyrich, AS et al. (1997). Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules. J Clin Invest 100:158–68.
   PubMed Web of Science ®Google Scholar
• Offenbacher S, Katz V, Fertik G et al. (1996). Periodontal disease as a possible risk factor for preterm low birth weight. J Periodontol 67:1103.
   PubMed Web of Science ®Google Scholar
• Orozco A, Gemmell E, Bickel M, Seymour GJ. (2007). Interleukin 18 and periodontal disease. J Dent Res 86:586–93.
   PubMed Web of Science ®Google Scholar
• Page RC. (1998). Periodontal diseases: a new paradigm. J Dent Educ 62:812–21.
   PubMedGoogle Scholar
• Page RC, Beck JD. (1997). Risk assessment for periodontal diseases. Int Dent J 47:61.
   PubMedGoogle Scholar
• Paraskevas S, Huizinga JD, Loos BG. (2008). A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 35:277–90.
   PubMed Web of Science ®Google Scholar
• Sanchez AR, Kupp LI, Sheridan PJ, Sanchez DR. (2004). Maternal chronic infection as a risk factor in preterm low birth weight infants: the link with periodontal infection. J Int Acad Periodontol 6:89–94.
   PubMedGoogle Scholar
• Scannapieco FA, Bush RB, Paju S. (2003). Association between periodontal disease and risk for atherosclerosis, cardiovascular disease, and stroke. A systematic review. J Periodontol 8:38–53.
   Google Scholar
• Shioi A, Katagi M, Okuno Y, Mori K, Jono S, Koyama H, Nishizawa Y. (2002). Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells roles of tumor necrosis factor-α and oncostatin M derived from macrophages. Circ Res 91:9–16.
   PubMed Web of Science ®Google Scholar
• Song HY, Kim MR, Lee MJ, Jeon ES, Bae YC, Jung JS et al. (2007). Oncostatin M decreases adiponectin expression and induces dedifferentiation of adipocytes by JAK3 and MEK dependent pathways. Int J Biochem Cel Biol 39:439–49.
   PubMed Web of Science ®Google Scholar
• Tanimura A, McGregor DH, Anderson HC. (1986). Calcification in atherosclerosis. I: Human studies. J Exp Pathol 2:261–73.
   PubMedGoogle Scholar
• Yao L, Pan J, Setiadi H, Patel KD, McEver RP. (1996). Interleukin 4 or oncostatin M induces a prolonged increase in P-selectin mRNA and protein in human endothelial cells. J Exp Med 184:81–92.
   PubMed Web of Science ®Google Scholar